Key facts
- This page summarizes Rady A. Johnson's Form 4 filing for PFIZER INC (PFE).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 27 Feb 2024, 13:46.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Tax liability
Tax liability
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
Footnote F2
The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
Footnote F3
The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
Footnote F4
Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.